1. Home
  2. LTRYW vs HUMAW Comparison

LTRYW vs HUMAW Comparison

Compare LTRYW & HUMAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lottery.com Inc.

LTRYW

Lottery.com Inc.

HOLD

Current Price

$0.01

Market Cap

0.0

Sector

Technology

ML Signal

HOLD

Logo Humacyte Inc. Warrant

HUMAW

Humacyte Inc. Warrant

HOLD

Current Price

$0.15

Market Cap

0.0

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LTRYW
HUMAW
Founded
N/A
2004
Country
United States
United States
Employees
12
220
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
LTRYW
HUMAW
Price
$0.01
$0.15
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
N/A
14.2K
Earning Date
N/A
03-21-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
N/A
$1.18
52 Week High
N/A
$1.34

Technical Indicators

Market Signals
Indicator
LTRYW
HUMAW
Relative Strength Index (RSI) 45.18 44.95
Support Level $0.01 $0.11
Resistance Level $0.01 $0.15
Average True Range (ATR) 0.00 0.03
MACD 0.00 0.00
Stochastic Oscillator 43.59 91.78

Price Performance

Historical Comparison
LTRYW
HUMAW

About LTRYW Lottery.com Inc.

Lottery.com Inc is a provider of domestic and international lottery products and services. As an independent third-party lottery game service, the Company offers a platform that it developed and operates to enable the remote purchase of legally sanctioned lottery games in the U.S. and abroad. The Company's revenue-generating activities are focused on (i) offering the Platform via the Lottery.com app and its websites to users located in the U.S. and international jurisdictions where the sale of lottery games is legal and its services are enabled for the remote purchase of legally sanctioned lottery games; (ii) offering an internally developed, created and operated business-to-business application programming interface of the Platform to enable commercial partners in permitted U.S.

About HUMAW Humacyte Inc. Warrant

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: